Document Detail

A new approach to antiglaucoma drugs: carbonic anhydrase inhibitors with or without NO donating moieties. Mechanism of action and preliminary pharmacology.
MedLine Citation:
PMID:  21815773     Owner:  NLM     Status:  Publisher    
The clinically used sulfonamide carbonic anhydrase (CA, EC inhibitor dorzolamide (DRZ), a new sulfonamide CA inhibitor also incorporating NO-donating moieties, NCX250, and isosorbide mononitrate (ISMN) (an NO-donating compound with no CA inhibitory properties) were investigated for their intraocular pressure (IOP) lowering effects in rabbits with carbomer-induced glaucoma. NCX250 was more effective than DRZ or ISMN on lowering IOP, increasing ocular hemodynamics, decreasing the inflammatory processes and ocular apoptosis in this animal model of glaucoma. NO participate to the regulation of IOP in glaucoma, having also antiapoptotic and anti-inflammatory effects. The ophthalmic artery, both systolic and diastolic velocities, were significantly reduced in NCX250-treated eyes in comparison to DRZ treated ones, suggesting thus a beneficial effect of NCX250 on the blood supply to the optic nerve. Combining CA inhibition with NO-donating moieties in the same compound offers an excellent approach for the management of glaucoma.
Francesca Fabrizi; Francesco Mincione; Teresa Somma; Gabriele Scozzafava; Fernando Galassi; Emanuela Masini; Francesco Impagnatiello; Claudiu T Supuran
Related Documents :
7546493 - Renin-angiotensin-aldosterone system, rr interval, and blood pressure variability durin...
11420763 - Activity of the neurohormonal system and its relationship to autonomic abnormalities in...
6517253 - A modified mie superlite exhaust valve incorporating a positive pressure safety relief ...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-8-4
Journal Detail:
Title:  Journal of enzyme inhibition and medicinal chemistry     Volume:  -     ISSN:  1475-6374     ISO Abbreviation:  -     Publication Date:  2011 Aug 
Date Detail:
Created Date:  2011-8-5     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101150203     Medline TA:  J Enzyme Inhib Med Chem     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Università degli Studi di Firenze, Department of Preclinical and Clinical Pharmacology , Florence , Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Inhibition of human carbonic anhydrase isozymes I, II and VI with a series of bisphenol, methoxy and...
Next Document:  Metal-based new sulfonamides: Design, synthesis, antibacterial, antifungal, and cytotoxic properties...